InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Eric Karas, Chief Commercial Officer, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 8 open-market SEC Form 4 transactions: 0 purchases worth $0 and 8 sales worth $1.3M, reported from Aug 19, 24 to Jun 12, 26. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 12, 26 | SPRYARS Pharmaceuticals, Inc. | SELL | 25.0K | $10.00 | $250K |
| Jul 1, 25 | SPRYARS Pharmaceuticals, Inc. | SELL | 15.0K | $16.99 | $255K |
| Jun 18, 25 | SPRYARS Pharmaceuticals, Inc. | SELL | 15.0K | $16.00 | $240K |
| Mar 20, 25 | SPRYARS Pharmaceuticals, Inc. | SELL | 10.0K | $14.00 | $140K |
| Dec 4, 24 | SPRYARS Pharmaceuticals, Inc. | SELL | 6.3K | $14.00 | $88K |
| Dec 2, 24 | SPRYARS Pharmaceuticals, Inc. | SELL | 3.7K | $14.11 | $52K |
| Sep 18, 24 | SPRYARS Pharmaceuticals, Inc. | SELL | 10.0K | $14.00 | $140K |
| Aug 19, 24 | SPRYARS Pharmaceuticals, Inc. | SELL | 10.0K | $14.00 | $140K |